OR WAIT 15 SECS
McDonnell Boehnen Hulbert & Berghoff LLP
Kevin Noonan is partner at McDonnell Boehnen Hulbert & Berghoff LLP and chair of the firm’s biotechnology and pharmaceuticals practice group.
Cell-based therapies are moving medical treatments forward, but intellectual property uncertainties may delay progress.